Viewing Study NCT00689104

Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug

Ignite Creation Date: 2025-12-24 @ 9:11 PM

Ignite Modification Date: 2025-12-25 @ 7:01 PM

Study NCT ID: NCT00689104

Status: COMPLETED

Last Update Posted: 2024-11-20

First Post: 2008-05-29

Is NOT Gene Therapy: False

Has Adverse Events: True

Brief Title: Study to Assess the Efficacy and Safety of the Beta-3 Agonist Mirabegron (YM178) in Patients With Symptoms of Overactive Bladder

Sponsor: Astellas Pharma Inc

Organization:

Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module Adverse Events Module Baseline Characteristics Module Participant Flow Module